Literature DB >> 22804671

Personality in DSM-5: helping delineate personality disorder content and framing the metastructure.

Robert F Krueger1, Nicholas R Eaton, Jaime Derringer, Kristian E Markon, David Watson, Andrew E Skodol.   

Abstract

The transition from the Diagnostic and Statistical Model of Mental Disorders (4th ed., text revision [DSM-IV-TR]; American Psychiatric Association, 2000 ) to the fifth edition (DSM-5) represents an unprecedented opportunity to integrate dimensional personality trait models into the official nosology. Not surprisingly, a variety of issues have arisen in contemplating this challenging integration. In this article, we address how a dimensional personality trait model could be a helpful component of DSM-5, from the perspective of our roles as work group members and advisors involved in the creation of a trait model and corresponding assessment instrument. We focus in particular on two potential roles for a trait model in DSM-5 that are under official consideration. First, a dimensional personality trait model might be helpful in delineating the content of personality disorders. Second, a trait model might assist in organizing the "metastructure" of DSM-5 (i.e., the arrangement of chapters and other broader classificatory rubrics).

Entities:  

Mesh:

Year:  2011        PMID: 22804671     DOI: 10.1080/00223891.2011.577478

Source DB:  PubMed          Journal:  J Pers Assess        ISSN: 0022-3891


  24 in total

Review 1.  Personality disorders in DSM-5: emerging research on the alternative model.

Authors:  Leslie C Morey; Kathryn T Benson; Alexander J Busch; Andrew E Skodol
Journal:  Curr Psychiatry Rep       Date:  2015-04       Impact factor: 5.285

2.  Personality Pathology and Interpersonal Problem Stability.

Authors:  Aidan G C Wright; Lori N Scott; Stephanie D Stepp; Michael N Hallquist; Paul A Pilkonis
Journal:  J Pers Disord       Date:  2015-01-06

3.  A dimensional liability model of age differences in mental disorder prevalence: evidence from a national sample.

Authors:  Nicolas Hoertel; Kibby McMahon; Mark Olfson; Melanie M Wall; Jorge Mario Rodríguez-Fernández; Cédric Lemogne; Frédéric Limosin; Carlos Blanco
Journal:  J Psychiatr Res       Date:  2015-03-28       Impact factor: 4.791

4.  Comparison of alternative models for personality disorders, II: 6-, 8- and 10-year follow-up.

Authors:  L C Morey; C J Hopwood; J C Markowitz; J G Gunderson; C M Grilo; T H McGlashan; M T Shea; S Yen; C A Sanislow; E B Ansell; A E Skodol
Journal:  Psychol Med       Date:  2011-12-02       Impact factor: 7.723

5.  Genetic variation in personality traits explains genetic overlap between borderline personality features and substance use disorders.

Authors:  Lauren R Few; Julia D Grant; Timothy J Trull; Dixie J Statham; Nicholas G Martin; Michael T Lynskey; Arpana Agrawal
Journal:  Addiction       Date:  2014-08-19       Impact factor: 6.526

6.  The value of suppressor effects in explicating the construct validity of symptom measures.

Authors:  David Watson; Lee Anna Clark; Michael Chmielewski; Roman Kotov
Journal:  Psychol Assess       Date:  2013-06-24

7.  Common Taxonomy of Traits and Symptoms: Linking Schizophrenia Symptoms, Schizotypy, and Normal Personality.

Authors:  David C Cicero; Katherine G Jonas; Kaiqiao Li; Greg Perlman; Roman Kotov
Journal:  Schizophr Bull       Date:  2019-10-24       Impact factor: 9.306

8.  Personality traits as an organizing framework for personality pathology.

Authors:  David Watson; Lee Anna Clark
Journal:  Personal Ment Health       Date:  2019-07-15

9.  Heterogeneity of interpersonal problems among depressed young adults: associations with substance abuse and pathological personality traits.

Authors:  Sindes Dawood; Katherine M Thomas; Aidan G C Wright; Christopher J Hopwood
Journal:  J Pers Assess       Date:  2013-04-05

10.  An interpersonal analysis of pathological personality traits in DSM-5.

Authors:  Aidan G C Wright; Aaron L Pincus; Christopher J Hopwood; Katherine M Thomas; Kristian E Markon; Robert F Krueger
Journal:  Assessment       Date:  2012-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.